| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 671033 | Null | 0.0237269271456697 | -0.023207131 |
| NSC 672868 | Null | 0.0237269271456697 | 0.072188478 |
| NSC 679240 | Null | 0.0237269271456697 | -0.22105994 |
| NSC 685964 | Null | 0.0237269271456697 | 0.07519193 |
| NSC 687523 | Null | 0.0237269271456697 | 0.077578735 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0237269271456697 | 0.2779165 |
| NSC 710326 | Null | 0.0237269271456697 | 0.08371633 |
| NSC 718630 | Null | 0.0237269271456697 | 0.20045929 |
| NSC 718781 | Erlotinib hydrochloride | 0.0237269271456697 | 0.40625223 |
| NSC 725098 | Null | 0.0237269271456697 | 0.016202081 |